February 7, 2024 by Chain Drug Review
CVS, fourth quarter
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health topped analysts’ forecasts for fourth quarter sales and profits, but cut its full year earnings outlook, citing rising medical costs that are hurting the insurance industry. Revenue for the three months ended December 31 climbed 11.9% from the year-ago period to $93.81 billion, beating Wall Street’s estimate of $90.41 billion.
April 20, 2023 by Chain Drug Review
fourth quarter, Rite Aid
Business, Featured Articles, Leading Headlines, Retail News
PHILADELPHIA — Rite Aid reported a net loss of $241.3 million, or $4.39 per share, for its fourth quarter, compared to a net loss of $389.1 million, or $7.18 per share in the year-ago period. The adjusted net loss of $68.2 million, or $1.24 per share, was wider than the 78 cents per share expected
February 8, 2023 by Chain Drug Review
CVS, fourth quarter
Featured Articles, Leading Headlines
WOONSOCKET, R.I. — CVS Health topped analysts’ expectations for fourth-quarter sales and earnings, led by strong insurance and retail results. Earnings per share for the three months ended Dec. 31 rose 0.5% from the year-ago period to $1.99 on revenue of $83.8 billion (up 9.5%). Wall Street had projected adjusted EPS of $1.92 on revenue
October 13, 2022 by Chain Drug Review
Brewer, fourth quarter, WBA
Featured Articles, Leading Headlines
DEERFIELD, Ill. _ Walgreens Boots Alliance topped analysts’ projections for fourth quarter revenue and earnings. WBA posted adjusted earnings per share of 80 cents for the period ended Aug. 31, exceeding Wall Street’s expectation of 77 cents. Revenue of $32.45 billion surpassed the predicted $32.09 billion. A fall off in COVID-19 vaccinations and a charge
April 14, 2022 by Chain Drug Review
fourth quarter, Heyward Donigan, Rite Aid
Featured Articles, Leading Headlines, Retail News
PHILADELPHIA — Rite Aid Thursday reported fourth quarter revenue that topped Wall Street’s forecast. The company posted revenue of $6.065 billion for the period ended February 26, up 2.5 percent from $5.917 billion in the year-ago quarter and far greater than the FactSet consensus of $5.470 billion. The gain was driven by retail segment growth,
October 14, 2021 by Chain Drug Review
fourth quarter, Roz Brewer, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance beat Wall Street’s expectations for fourth quarter revenue and earnings, with COVID-19 vaccinations and tests boosting traffic and demand rising for cough-cold medications and vitamins. Walgreens administered 13.5 million vaccines during the three months ended August 31 — almost double the 7 million it had expected to provide. Adjusted
October 15, 2020 by Chain Drug Review
fourth quarter, Pessina, Walgreens, WBA
Featured Articles, Leading Headlines, News, Pharmacy, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) on Thursday projected single-digit profit growth in fiscal 2021 after reporting better-than-expected fourth-quarter earnings, helped by higher sales at U.S. stores. Sales in U.S. stores in the quarter ended August 31 advanced 3.6% to $27.0 billion, with same-store sales rising by the same amount. WBA said it anticipates
April 29, 2015 by Chain Drug Review
fiscal 2015, fourth quarter, François Coutu, Jean Coutu Group, PJC Jean Coutu
Business, Leading Headlines, Retail News
LONGUEUIL, Quebec — The Jean Coutu Group reported increased corporate and retail store sales for its fiscal 2015 fourth quarter and full year but saw net income dip in both periods. The Canadian drug chain said Wednesday that for the fourth quarter ended Feb. 28, sales in its franchised store network total $1.099 billion (Canadian), up
March 5, 2015 by Chain Drug Review
fiscal 2015 sales, fourth quarter, Rite Aid, same-store sales
Business, Retail News
CAMP HILL, Pa. — Rite Aid Corp. kept up its same-store sales momentum in February and reported increased sales for the fourth quarter and fiscal year, the latter finishing in line with the company’s forecast. Rite Aid said Thursday that for the five weeks ended Feb. 28, comparable-store sales rose 3.3% year over year. The